Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 12, 2020

SELL
$11.15 - $24.64 $119,305 - $263,648
-10,700 Closed
0 $0
Q1 2020

May 12, 2020

BUY
$8.75 - $16.3 $93,625 - $174,410
10,700 New
10,700 $126,000
Q3 2018

Nov 02, 2018

SELL
$6.4 - $9.85 $425,600 - $655,025
-66,500 Closed
0 $0
Q2 2018

Aug 03, 2018

BUY
$6.9 - $9.9 $458,850 - $658,350
66,500 New
66,500 $552,000

Others Institutions Holding CYTK

About CYTOKINETICS INC


  • Ticker CYTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,144,096
  • Market Cap $2.92B
  • Description
  • Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...
More about CYTK
Track This Portfolio

Track Virginia Retirement Systems Et Al Portfolio

Follow Virginia Retirement Systems Et Al and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virginia Retirement Systems Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Virginia Retirement Systems Et Al with notifications on news.